Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
Roser PinyolRobert MontalLaia BassaganyasDaniela SiaTadatoshi TakayamaGar-Yang ChauVincenzo MazzaferroSasan RoayaieHan Chu LeeYoshihiro SakamotoZhongyang ZhangSara TorrecillaAgrin MoeiniLeonardo Rodriguez-CarunchioEdward GaneChris VerslypeAdina Emilia CroitoruUmberto CilloManuel de la MataLuigi LupoSimone StrasserJoong-Won ParkJordi CampsManel SoléSwan N ThungAugusto VillanuevaCarol PenaGerold MeinhardtJordi BruixJosep M LlovetPublished in: Gut (2018)
NCT00692770.